MTOR and central nervous system cancer: Sustained and constitutive activation of multiple key RTKs is a primary driving force for glioma cell progression 53, 54, causing hyperactivation of downstream mitogenic pathways, including PI3K-Akt-mTOR and Erk-MAPK 54, 55.